このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Torrent Pharmaceuticals マネジメント
マネジメント 基準チェック /34
現在、CEO に関する十分な情報がありません。
主要情報
Samir Mehta
最高経営責任者
₹230.0m
報酬総額
| CEO給与比率 | 0.02% |
| CEO在任期間 | 35.4yrs |
| CEOの所有権 | 0.0002% |
| 経営陣の平均在職期間 | 2.4yrs |
| 取締役会の平均在任期間 | 4.3yrs |
経営陣の近況
Recent updates
Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) P/E Is On The Mark
Apr 16
Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?
Mar 03Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹22.00
Feb 05Investors Interested In Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Earnings
Jan 07Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Rather Sparingly
Nov 14Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jun 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Mar 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jul 25Torrent Pharmaceuticals' (NSE:TORNTPHARM) Soft Earnings Don't Show The Whole Picture
Jun 02Estimating The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
May 25A Look At The Intrinsic Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
Feb 18Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹25.00
Jan 27Here's Why Torrent Pharmaceuticals (NSE:TORNTPHARM) Can Manage Its Debt Responsibly
Jan 04Here's Why I Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Is An Interesting Stock
Dec 14A Look At The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
Nov 07Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Sep 30Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Deserve A Spot On Your Watchlist?
Sep 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jul 02I Ran A Stock Scan For Earnings Growth And Torrent Pharmaceuticals (NSE:TORNTPHARM) Passed With Ease
Jun 01Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Shares Could Be 30% Above Their Intrinsic Value Estimate
May 14Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?
Mar 23The Torrent Pharmaceuticals (NSE:TORNTPHARM) Share Price Has Gained 84% And Shareholders Are Hoping For More
Mar 02Is It Smart To Buy Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Before It Goes Ex-Dividend?
Feb 10Do Torrent Pharmaceuticals's (NSE:TORNTPHARM) Earnings Warrant Your Attention?
Jan 19Should You Be Impressed By Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) ROE?
Dec 29Is Torrent Pharmaceuticals (NSE:TORNTPHARM) Using Too Much Debt?
Dec 08
Investors Who Bought Torrent Pharmaceuticals (NSE:TORNTPHARM) Shares Three Years Ago Are Now Up 118%
Nov 16The Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Second-Quarter Results Are Out And Analysts Have Published New Forecasts
Oct 28CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | ₹17b |
| Dec 31 2023 | n/a | n/a | ₹15b |
| Sep 30 2023 | n/a | n/a | ₹13b |
| Jun 30 2023 | n/a | n/a | ₹13b |
| Mar 31 2023 | ₹230m | ₹40k | ₹12b |
| Dec 31 2022 | n/a | n/a | ₹8b |
| Sep 30 2022 | n/a | n/a | ₹8b |
| Jun 30 2022 | n/a | n/a | ₹8b |
| Mar 31 2022 | ₹200m | ₹40k | ₹8b |
| Dec 31 2021 | n/a | n/a | ₹12b |
| Sep 30 2021 | n/a | n/a | ₹13b |
| Jun 30 2021 | n/a | n/a | ₹13b |
| Mar 31 2021 | ₹200m | ₹40k | ₹13b |
| Dec 31 2020 | n/a | n/a | ₹12b |
| Sep 30 2020 | n/a | n/a | ₹12b |
| Jun 30 2020 | n/a | n/a | ₹11b |
| Mar 31 2020 | ₹200m | ₹40k | ₹10b |
| Dec 31 2019 | n/a | n/a | ₹6b |
| Sep 30 2019 | n/a | n/a | ₹6b |
| Jun 30 2019 | n/a | n/a | ₹5b |
| Mar 31 2019 | ₹150m | ₹40k | ₹4b |
| Dec 31 2018 | n/a | n/a | ₹8b |
| Sep 30 2018 | n/a | n/a | ₹6b |
| Jun 30 2018 | n/a | n/a | ₹7b |
| Mar 31 2018 | ₹150m | ₹40k | ₹7b |
報酬と市場: Samirの 総報酬 ($USD 2.75M ) は、 Indian市場 ($USD 1.05M ) の同規模の企業の平均を上回っています。
報酬と収益: Samirの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Samir Mehta (60 yo)
35.4yrs
在職期間
₹230,040,000
報酬
Mr. Samir Uttamlal Mehta, B.Com., MBA serves as a Managing Director of Torrent Pharmaceuticals Limited since 1989. Mr. Mehta served as Managing Director of Torrent Power Limited. Mr. Mehta has been associa...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Executive Chairman & MD | no data | ₹230.04m | 0.00024% ₹ 2.3m | |
| Executive Director of Operations & Whole-Time Director | no data | ₹58.87m | データなし | |
| Whole-Time Director | 1.8yrs | ₹20.59m | 0.000060% ₹ 574.8k | |
| Executive Director of Finance & CFO | 5.8yrs | ₹16.30m | データなし | |
| Company Secretary & Compliance Officer | 1.8yrs | データなし | データなし | |
| Chief Customer Service Officer | 3yrs | データなし | データなし | |
| Vice President of Human Resource | no data | ₹6.56m | データなし | |
| Vice President of Works | no data | ₹8.25m | データなし | |
| Vice President of Works | no data | ₹7.28m | データなし | |
| Vice President of Finance | no data | ₹6.35m | データなし | |
| Executive Director of International Business | no data | データなし | データなし |
2.4yrs
平均在職期間
56yo
平均年齢
経験豊富な経営陣: TORNTPHARMの経営陣は 経験豊富 であると考えられます ( 2.4年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Executive Chairman & MD | 35.4yrs | ₹230.04m | 0.00024% ₹ 2.3m | |
| Executive Director of Operations & Whole-Time Director | 4.3yrs | ₹58.87m | データなし | |
| Whole-Time Director | 1.8yrs | ₹20.59m | 0.000060% ₹ 574.8k | |
| Chairman Emeritus | 9.9yrs | データなし | 0.00030% ₹ 2.9m | |
| Independent Director | less than a year | データなし | データなし | |
| Independent Director | 1.9yrs | ₹4.20m | データなし | |
| Independent Director | 5.8yrs | ₹6.90m | 0.00052% ₹ 5.0m | |
| Independent Director | 5.3yrs | ₹7.90m | データなし | |
| Independent Director | 2.1yrs | ₹7.10m | データなし |
4.3yrs
平均在職期間
59yo
平均年齢
経験豊富なボード: TORNTPHARMの 取締役会 は 経験豊富 であると考えられます ( 4.3年の平均在任期間)。